Blog

August 7, 2025

By: List Labs

Live Biotherapeutic Products (LBPs) are emerging as powerful tools in the fight against chronic illness, infections, and even cancer. These living microbial therapeutics hold immense promise—but their very nature presents unique challenges, particularly when it comes to quality control. Standard microbiological examination methods, designed for non-living products, often fall short when applied to LBPs. In […]

August 5, 2025

By: List Labs

As the field of live biotherapeutic products (LBPs) rapidly advances, so too does the need for rigorous, nuanced microbiological quality control (QC). LBPs—live microorganisms used to prevent, treat, or cure diseases—present unique challenges when meeting regulatory safety standards. Traditional compendial methods were not designed for products teeming with live bacteria. In this blog, we explore […]

6 Common Pitfalls in CDMO Partnerships—and How to Avoid Them

March 18, 2025

By: Gary Henderson

6 Common Pitfalls in CDMO Partnerships—and How to Avoid Them Intro From small biotech startups to global pharmaceutical giants, many companies rely on Contract Development and Manufacturing Organizations (CDMOs) to bring their products to market more efficiently. Outsourcing can accelerate timelines and reduce up-front investment in facilities, but it also brings risks if not managed […]

June 23, 2023

By: List Labs

Reasons to choose List Labs as your Microbiome CDMO: We support a very diverse offering in Bacterial Manufacturing. We are a passionate and transparent CDMO. We are flexible and cohesive enough to be an extension of our customer's team. We offer end-to-end solutions for our customers. Learn more about List Labs' 45 years of experience [...]

Microbiome CDMO Spotlight Interview: Stacy Burns-Guydish, President List Labs

November 10, 2022

By: List Labs

This interview between Jessica Thompson from Kisaco Research and Stacy Burns-Guydish, PhD, President of List Labs, talks about the growth of the Microbiome field for Microbiome CDMOs and digs deep into the Live Biotherapeutics side of this burgeoning industry. To get further insight into the future of the Microbiome field, check out the video below: […]

CDMO Services: Greater Capacity and End-to-End LBP Manufacturing

September 19, 2022

By: List Labs

List Labs is an experienced contract development and manufacturing organization (CDMO) harnessing bacteria’s potential for a healthier world. We offer a refreshingly flexible approach to clients seeking a CDMO for Live Biotherapeutic Products (LBP) derived from beneficial bacteria. Partner with List Labs as your CDMO and experience our uniquely collaborative and transparent culture. Why Choose […]